These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31998416)

  • 1. Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
    Liang J; Liu Z; Pei T; Xiao Y; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Yin X; Chen N; Wei X; Lu Y; Zhu Y
    Dis Markers; 2020; 2020():5354825. PubMed ID: 31998416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.
    Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M
    Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma.
    Yu YH; Xu JH; Chen H; Lin YX; Ou-Yang J; Zhang ZY
    Kaohsiung J Med Sci; 2024 Oct; 40(10):926-933. PubMed ID: 39210603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of GMNN predicts malignant progression and poor prognosis in ACC.
    Zhao X; Zhang X; Shao S; Yang Q; Shen C; Yang X; Jiao W; Liu J; Wang Y
    Eur J Med Res; 2022 Dec; 27(1):301. PubMed ID: 36539849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical Carcinoma Steroid Profiles:
    Muzzi JCD; Magno JM; Cardoso MA; de Moura J; Castro MAA; Figueiredo BC
    Front Endocrinol (Lausanne); 2021; 12():672319. PubMed ID: 34194394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
    Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
    J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
    Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
    Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical significance of VISTA and PD-L1 in adrenocortical carcinoma.
    Zhang Z; Li M; Wang J; Liu M; Chen H; Lou Y; Wang Y; Sun Q; Zhu D; Li P; Bi Y
    Endocr Relat Cancer; 2022 May; 29(7):403-413. PubMed ID: 35521773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
    Zhu B; Zhi Q; Xie Q; Wu X; Gao Y; Chen X; Shi L
    J Trace Elem Med Biol; 2019 Dec; 56():52-59. PubMed ID: 31442954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
    Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
    Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
    Liang J; Liu Z; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Wei X; Lu Y; Zhu Y
    Endocrine; 2020 Feb; 67(2):449-456. PubMed ID: 31786772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma.
    Fenske W; Völker HU; Adam P; Hahner S; Johanssen S; Wortmann S; Schmidt M; Morcos M; Müller-Hermelink HK; Allolio B; Fassnacht M
    Endocr Relat Cancer; 2009 Sep; 16(3):919-28. PubMed ID: 19465749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes.
    Parianos C; Kyriakopoulos G; Kostakis ID; Nasiri-Ansari N; Aggeli C; Dimitriadi A; Angelousi A; Papavassiliou AG; Kaltsas GA; Zografos G; Kassi E
    Horm Metab Res; 2021 Nov; 53(11):709-716. PubMed ID: 34740271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
    Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ
    Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
    Wang C; Sun Y; Wu H; Zhao D; Chen J
    Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.